Seegene Using Molzym DNA-Enrichment Tech for Multiplex PCR Sepsis Test
March 24, 2011
Seegene Using Molzym DNA-Enrichment Tech for Multiplex PCR Sepsis Test
Molzym is providing its MolYsis microbial DNA-enrichment technology, which the company claims enables up to 40,000-fold DNA enrichment over conventional technologies, on the front end of Seegene's Magicplex Sepsis test.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Seegene Adds Multiplex HRM Tech to Stable of MDx Assay Chemistries
July 21, 2011 / PCR Insider - Seegene Develops Highly Multiplexed Quantitative Real-Time PCR Chemistry, HPV Genotyping Assay
May 31, 2012 / PCR Insider - Akonni Wins $300K NIH Grant to Combine Flow Strip with PCR Array for Respiratory Dx Panel
March 15, 2012 / PCR Insider - Seegene to Use Biosearch Fluorophores, Oligos in Molecular Dx Platforms
October 21, 2010 / PCR Insider - Dx Focus: Clinical and Regulatory PCR and Nucleic Acid Testing News
July 29, 2010 / PCR Insider